Convenio Suministro Adquisición de Levetiracetam para el Hospital San Camilo
CONVENIO SUMINISTRO ADQUISICIÓN DE LEVETIRACETAM PARA EL HOSPITAL SAN CAMILO
3 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1100719-604-SE26 | 03-07-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $3.266.550 |
| 1100719-497-SE26 | 05-06-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $3.266.550 |
| 1100719-407-SE26 | 11-05-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $2.907.230 |
| 1100719-317-SE26 | 06-04-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $2.177.700 |
| 1100719-194-SE26 | 10-03-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $5.084.930 |
| 1100719-113-SE26 | 30-01-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $3.636.759 |
| 1100719-18-SE26 | 13-01-2026 | Glaxosmithkline Chile Farmaceutica Limitada | $3.636.759 |
| 1100719-2673-SE25 | 02-12-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.177.700 |
| 1100719-2607-SE25 | 30-10-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.907.230 |
| 1100719-1099-SE25 | 06-10-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.907.230 |
| 1100719-1012-SE25 | 02-09-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $3.266.550 |
| 1100719-925-SE25 | 31-07-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.547.909 |
| 1100719-814-SE25 | 30-06-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.907.230 |
| 1100719-704-SE25 | 30-05-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.907.230 |
| 1100719-684-SE25 | 16-05-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.907.230 |
| 1100719-160-SE25 | 26-02-2025 | Glaxosmithkline Chile Farmaceutica Limitada | $2.907.230 |
| 1100719-1042-SE24 | 06-11-2024 | Glaxosmithkline Chile Farmaceutica Limitada | $7.262.630 |
| 1100719-965-SE24 | 10-10-2024 | Glaxosmithkline Chile Farmaceutica Limitada | $3.266.550 |
| 1100719-815-SE24 | 28-08-2024 | Glaxosmithkline Chile Farmaceutica Limitada | $3.266.550 |
| 1100719-745-SE24 | 29-07-2024 | Glaxosmithkline Chile Farmaceutica Limitada | $2.177.700 |
| 1100719-695-SE24 | 08-07-2024 | Glaxosmithkline Chile Farmaceutica Limitada | $2.547.909 |
| 1100719-622-SE24 | 24-06-2024 | Glaxosmithkline Chile Farmaceutica Limitada | $2.547.909 |
Fuente original:ficha mercadopublico.cl
